Elai Davicioni
Fondateur chez Veracyte SD, Inc.
Profil
Elai Davicioni is the founder of Decipher Biosciences, Inc. He is currently the President & Chief Scientific Officer at GenomeDx, Inc. (California).
Previously, he held the position of President & Chief Executive Officer at Genome Diagnostics, Inc. and Principal at Compugen, Inc. He obtained a doctorate degree from the University of Southern California and completed his undergraduate and graduate studies at Ben-Gurion University of the Negev.
Postes actifs de Elai Davicioni
| Sociétés | Poste | Début |
|---|---|---|
Veracyte SD, Inc.
 Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Decipher Biosciences, Inc. is a commercial-stage precision oncology company which engages in patient care improvement. The Company?s differentiated approach measures the biological activity of a patient?s entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to improve therapy selection and accelerate adoption of new therapies into the standard of care. Its novel prostate cancer genomic testing products examine the underlying biology of a patient?s tumor, enabling physicians to select an optimal therapy. The firm?s whole transcriptome analysis of clinical patient samples from its commercial channel and its participation in practice-changing clinical trials has allowed it to build and expand its Decipher GRID database GRID. The company was founded by Elai Davicioni, Timothy J. Triche, Bruce A. Schmidt, and Jonathan D. Buckley and is headquartered in San Diego, CA. | Fondateur | 16/12/2008 |
GenomeDx, Inc. (California)
 GenomeDx, Inc. (California) Miscellaneous Commercial ServicesCommercial Services GenomeDx, Inc. operates as a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers. It offers Decipher and Guidance test. The company is headquartered in San Diego, CA. | President | - |
Anciens postes connus de Elai Davicioni
| Sociétés | Poste | Fin |
|---|---|---|
Compugen, Inc.
 Compugen, Inc. Information Technology ServicesTechnology Services Compugen, Inc. provides technology solutions and services. Its services include managed, professional, support and maintenance, asset disposal and recycling, hardware and software management and financing services. The company was founded by Harry Zarek in 1981 and is headquartered in Richmond Hill, Canada. | Corporate Officer/Principal | - |
Genome Diagnostics, Inc.
 Genome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Genome Diagnostics, Inc. develops products for the medical diagnostics and personalized medicine markets. It focuses on harnessing the wealth of information encoded in the human genome to better address acute medical needs in oncology. The company was founded in 2007 and is headquartered in Pasadena, CA. | President | - |
Formation de Elai Davicioni
| University of Southern California | Doctorate Degree |
| Ben-Gurion University of the Negev | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Genome Diagnostics, Inc.
Genome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Genome Diagnostics, Inc. develops products for the medical diagnostics and personalized medicine markets. It focuses on harnessing the wealth of information encoded in the human genome to better address acute medical needs in oncology. The company was founded in 2007 and is headquartered in Pasadena, CA. | Health Services |
Compugen, Inc.
Compugen, Inc. Information Technology ServicesTechnology Services Compugen, Inc. provides technology solutions and services. Its services include managed, professional, support and maintenance, asset disposal and recycling, hardware and software management and financing services. The company was founded by Harry Zarek in 1981 and is headquartered in Richmond Hill, Canada. | Technology Services |
Veracyte SD, Inc.
Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Decipher Biosciences, Inc. is a commercial-stage precision oncology company which engages in patient care improvement. The Company?s differentiated approach measures the biological activity of a patient?s entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to improve therapy selection and accelerate adoption of new therapies into the standard of care. Its novel prostate cancer genomic testing products examine the underlying biology of a patient?s tumor, enabling physicians to select an optimal therapy. The firm?s whole transcriptome analysis of clinical patient samples from its commercial channel and its participation in practice-changing clinical trials has allowed it to build and expand its Decipher GRID database GRID. The company was founded by Elai Davicioni, Timothy J. Triche, Bruce A. Schmidt, and Jonathan D. Buckley and is headquartered in San Diego, CA. | Commercial Services |
GenomeDx, Inc. (California)
GenomeDx, Inc. (California) Miscellaneous Commercial ServicesCommercial Services GenomeDx, Inc. operates as a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers. It offers Decipher and Guidance test. The company is headquartered in San Diego, CA. | Commercial Services |
